Abeona Therapeutics ROE 2006-2019 | ABEO

Current and historical return on equity (ROE) values for Abeona Therapeutics (ABEO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Abeona Therapeutics ROE for the three months ending March 31, 2019 was -45.58%.
Abeona Therapeutics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $-0.07B $0.12B -46.18%
2018-12-31 $-0.06B $0.13B -37.13%
2018-09-30 $-0.05B $0.15B -28.92%
2018-06-30 $-0.04B $0.16B -24.41%
2018-03-31 $-0.03B $0.17B -24.71%
2017-12-31 $-0.03B $0.17B -23.37%
2017-09-30 $-0.03B $0.09B -26.74%
2017-06-30 $-0.02B $0.09B -26.51%
2017-03-31 $-0.02B $0.10B -27.59%
2016-12-31 $-0.02B $0.10B -31.83%
2016-09-30 $-0.02B $0.06B -27.91%
2016-06-30 $-0.02B $0.06B -31.34%
2016-03-31 $-0.02B $0.07B -26.97%
2015-12-31 $-0.01B $0.07B -27.45%
2015-09-30 $-0.03B $0.07B -70.92%
2015-06-30 $-0.02B $0.06B -221.05%
2015-03-31 $-0.03B $0.00B 240.00%
2014-12-31 $-0.03B $0.01B 176.47%
2014-09-30 $-0.02B $-0.03B 86.36%
2014-06-30 $-0.02B $-0.03B 101.41%
2014-03-31 $-0.00B $-0.02B 29.09%
2013-12-31 $0.00B $-0.02B -7.41%
2013-09-30 $0.02B $-0.01B -157.14%
2013-06-30 $0.01B $-0.01B -35.96%
2013-03-31 $-0.00B $-0.01B 14.81%
2012-12-31 $-0.01B $-0.02B 42.11%
2012-09-30 $-0.03B $-0.05B 107.83%
2012-06-30 $-0.02B $-0.03B 69.57%
2012-03-31 $-0.01B $-0.02B 32.94%
2011-12-31 $-0.00B $-0.02B 18.18%
2011-09-30 $-0.00B $-0.02B 8.79%
2011-06-30 $-0.02B $-0.02B 61.22%
2011-03-31 $-0.01B $-0.02B 52.17%
2010-12-31 $-0.01B $-0.02B 40.45%
2010-09-30 $-0.02B $-0.03B 84.21%
2010-06-30 $-0.01B $-0.02B 59.26%
2010-03-31 $-0.02B $-0.02B 83.12%
2009-12-31 $-0.02B $-0.03B 115.94%
2009-09-30 $-0.01B $-0.02B 105.66%
2009-06-30 $-0.01B $-0.01B 127.27%
2009-03-31 $-0.03B $-0.01B 294.12%
2008-12-31 $-0.04B $-0.01B 626.09%
2008-09-30 $-0.06B $-0.01B 2218.18%
2008-06-30 $-0.06B $-0.00B 1104.76%
2008-03-31 $-0.05B $-0.00B 557.58%
2007-12-31 $-0.04B $0.00B 313.04%
2007-09-30 $-0.01B $-0.02B 77.19%
2007-06-30 $-0.01B $-0.02B 81.48%
2007-03-31 $-0.01B $-0.01B 96.00%
2006-12-31 $-0.01B $-0.01B 115.56%
2006-09-30 $-0.00B $-0.01B 30.77%
2006-06-30 $-0.00B $-0.01B 31.58%
2006-03-31 $-0.00B $-0.01B 42.11%
2005-12-31 $-0.00B $-0.00B 10.53%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.264B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $85.546B 10.39
Celgene (CELG) United States $68.622B 11.63
Illumina (ILMN) United States $51.613B 59.81
Biogen (BIIB) United States $44.941B 8.53
Vertex Pharmaceuticals (VRTX) United States $44.509B 53.80
Regeneron Pharmaceuticals (REGN) United States $33.983B 15.97
Alexion Pharmaceuticals (ALXN) United States $26.940B 15.25
Incyte (INCY) United States $17.550B 71.17
BioMarin Pharmaceutical (BMRN) United States $15.072B 0.00
Exact Sciences (EXAS) United States $14.452B 0.00
Seattle Genetics (SGEN) United States $11.552B 0.00
Array BioPharma (ARRY) United States $10.298B 0.00
Sarepta Therapeutics (SRPT) United States $9.423B 0.00
QIAGEN (QGEN) Netherlands $8.939B 29.36
Bio-Rad Laboratories (BIO.B) United States $8.674B 45.98
Bio-Techne Corp (TECH) United States $7.848B 53.55
Guardant Health (GH) United States $7.801B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.617B 0.00
Bluebird Bio (BLUE) United States $6.764B 0.00
Exelixis (EXEL) United States $6.235B 15.89
Amarin (AMRN) Ireland $6.204B 0.00
Galapagos (GLPG) Belgium $6.199B 0.00
Ascendis Pharma (ASND) Denmark $5.393B 0.00
BeiGene (BGNE) Cayman Islands $5.317B 0.00
Moderna (MRNA) United States $5.189B 0.00
Blueprint Medicines (BPMC) United States $4.614B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.051B 0.00
Spark Therapeutics (ONCE) United States $3.829B 0.00
China Biologic Products (CBPO) China $3.666B 23.28
ACADIA Pharmaceuticals (ACAD) United States $3.665B 0.00
Repligen (RGEN) United States $3.660B 91.18
Mirati Therapeutics (MRTX) United States $3.620B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.500B 0.00
Alkermes (ALKS) Ireland $3.480B 0.00
Allogene Therapeutics (ALLO) United States $3.330B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.113B 0.00
UniQure (QURE) Netherlands $3.067B 0.00
Global Blood Therapeutics (GBT) United States $3.059B 0.00
Arena Pharmaceuticals (ARNA) United States $2.837B 5.76
Amicus Therapeutics (FOLD) United States $2.779B 0.00
Lion Biotechnologies (IOVA) United States $2.711B 0.00
Medicines (MDCO) United States $2.647B 0.00
Reata Pharmaceuticals (RETA) United States $2.551B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.547B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.505B 0.00
Immunomedics (IMMU) United States $2.500B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.490B 0.00
Halozyme Therapeutics (HALO) United States $2.351B 0.00
Emergent Biosolutions (EBS) United States $2.329B 20.23
NeoGenomics (NEO) United States $2.301B 150.63
Akcea Therapeutics (AKCA) United States $2.263B 0.00
MyoKardia (MYOK) United States $2.204B 0.00
Ligand Pharmaceuticals (LGND) United States $2.190B 18.14
Acceleron Pharma (XLRN) United States $2.021B 0.00
Insmed (INSM) United States $1.965B 0.00
Genomic Health (GHDX) United States $1.931B 41.02
REGENXBIO (RGNX) United States $1.884B 0.00
Allakos (ALLK) United States $1.867B 0.00
Denali Therapeutics (DNLI) United States $1.867B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.856B 0.00
Myriad Genetics (MYGN) United States $1.817B 18.07
AnaptysBio (ANAB) United States $1.817B 0.00
Audentes Therapeutics (BOLD) United States $1.765B 0.00
Cambrex (CBM) United States $1.454B 18.38
Nabriva Therapeutics AG (NBRV) Ireland $1.443B 0.00
Innoviva (INVA) United States $1.441B 3.99
Alector (ALEC) United States $1.402B 0.00
Gossamer Bio (GOSS) United States $1.390B 0.00
Apellis Pharmaceuticals (APLS) United States $1.382B 0.00
Coherus BioSciences (CHRS) United States $1.356B 0.00
Aimmune Therapeutics (AIMT) United States $1.284B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.255B 0.00
Fate Therapeutics (FATE) United States $1.246B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.243B 0.00
Eidos Therapeutics (EIDX) United States $1.209B 0.00
Athenex (ATNX) United States $1.194B 0.00
Rubius Therapeutics (RUBY) United States $1.150B 0.00
Epizyme (EPZM) United States $1.128B 0.00
Sangamo Therapeutics (SGMO) United States $1.126B 0.00
Editas Medicine (EDIT) United States $1.113B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.082B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.040B 0.00
CORTEXYME INC (CRTX) United States $1.026B 0.00
Atara Biotherapeutics (ATRA) United States $1.022B 0.00
Codexis (CDXS) United States $0.970B 0.00
RA PHARMCTL INC (RARX) United States $0.962B 0.00
WAVE Life Sciences (WVE) Singapore $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.928B 0.00
NGM Biopharmaceuticals (NGM) United States $0.918B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.881B 0.00
ANI Pharmaceuticals (ANIP) United States $0.873B 15.49
Inotek Pharmaceuticals (RCKT) United States $0.851B 0.00
Principia Biopharma (PRNB) United States $0.841B 0.00
Twist Bioscience (TWST) United States $0.826B 0.00
Retrophin (RTRX) United States $0.822B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.789B 37.25
Cara Therapeutics (CARA) United States $0.789B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.786B 0.00
Intra-Cellular Therapies (ITCI) United States $0.780B 0.00
Axsome Therapeutics (AXSM) United States $0.772B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.771B 0.00
Clovis Oncology (CLVS) United States $0.748B 0.00
Kura Oncology (KURA) United States $0.744B 0.00
G1 THERAPEUTICS (GTHX) United States $0.740B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.731B 0.00
Adverum Biotechnologies (ADVM) United States $0.730B 0.00
Vericel (VCEL) United States $0.725B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.711B 0.00
Arvinas (ARVN) United States $0.709B 0.00
MeiraGTx Holdings (MGTX) United States $0.691B 0.00
Myovant Sciences (MYOV) United Kingdom $0.677B 0.00
Intellia Therapeutics (NTLA) United States $0.671B 0.00
Zymeworks (ZYME) Canada $0.662B 0.00
Stemline Therapeutics (STML) United States $0.655B 0.00
Zealand Pharma (ZEAL) Denmark $0.643B 7.51
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.637B 0.00
Precision BioSciences (DTIL) United States $0.632B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.627B 0.00
Cytokineticsorporated (CYTK) United States $0.621B 0.00
Heska (HSKA) United States $0.610B 62.48
Cellectis (CLLS) France $0.607B 0.00
Viking Therapeutics (VKTX) United States $0.586B 0.00
Anika Therapeutics (ANIK) United States $0.576B 19.67
Puma Biotechnology (PBYI) United States $0.526B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.525B 0.00
Revance Therapeutics (RVNC) United States $0.498B 0.00
Scholar Rock Holding (SRRK) United States $0.494B 0.00
DBV Technologies (DBVT) France $0.492B 0.00
BeyondSpring (BYSI) United States $0.489B 0.00
CytomX Therapeutics (CTMX) United States $0.489B 0.00
UROGEN PHARMA (URGN) United States $0.489B 0.00
Mesoblast (MESO) Australia $0.465B 0.00
Magenta Therapeutics (MGTA) United States $0.460B 0.00
ObsEva SA (OBSV) Switzerland $0.457B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.456B 0.00
Synthorx (THOR) United States $0.450B 0.00
Sorrento Therapeutics (SRNE) United States $0.446B 0.00
Kodiak Sciences (KOD) United States $0.443B 0.00
Provention Bio (PRVB) United States $0.424B 0.00
Krystal Biotech (KRYS) United States $0.415B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.413B 0.00
Replimune (REPL) United States $0.413B 0.00
Kaleido Biosciences (KLDO) $0.412B 0.00
MediciNova (MNOV) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.403B 0.00
UNITY Biotechnology (UBX) $0.393B 0.00
AC Immune SA (ACIU) Switzerland $0.392B 25.22
Prothena (PRTA) Ireland $0.388B 0.00
BioDelivery Sciences (BDSI) United States $0.387B 0.00
Agenus (AGEN) United States $0.387B 0.00
Albireo Pharma (ALBO) United States $0.384B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.378B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Acorda Therapeutics (ACOR) United States $0.370B 6.51
Gritstone Oncology (GRTS) United States $0.368B 0.00
PDL BioPharma (PDLI) United States $0.358B 8.54
Biofrontera AG Sponsored ADR (BFRA) Germany $0.358B 0.00
Senesco Technologies (ELOX) United States $0.355B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.343B 0.00
ResTORbio (TORC) United States $0.338B 0.00
NEXTCURE INC (NXTC) United States $0.332B 0.00
AVROBIO (AVRO) United States $0.326B 0.00
Kindred Biosciences (KIN) United States $0.320B 0.00
LogicBio Therapeutics (LOGC) United States $0.313B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.305B 0.00
Merus (MRUS) Netherlands $0.302B 0.00
PHASEBIO PHARMA (PHAS) United States $0.301B 0.00
Cyclerion Therapeutics (CYCN) United States $0.295B 0.00
Palatin Technologies (PTN) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.274B 0.00
Geron (GERN) United States $0.274B 0.00
Athersys (ATHX) United States $0.274B 0.00
Syros Pharmaceuticals (SYRS) United States $0.272B 0.00
Dynavax Technologies (DVAX) United States $0.267B 0.00
XBiotech (XBIT) United States $0.263B 0.00
Chiasma (CHMA) United States $0.257B 0.00
Sutro Biopharma (STRO) United States $0.255B 0.00
Inovio Pharmaceuticals (INO) United States $0.253B 0.00
Constellation Pharmaceuticals (CNST) United States $0.248B 0.00
Urovant Sciences (UROV) United States $0.247B 0.00
Synlogic (SYBX) United States $0.241B 0.00
Evelo Biosciences (EVLO) United States $0.241B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.234B 0.00
Five Prime Therapeutics (FPRX) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Neothetics (EVFM) United States $0.230B 0.00
Celcuity (CELC) United States $0.230B 0.00
AXCELLA HEALTH (AXLA) United States $0.229B 0.00
Kadmon Holdings (KDMN) United States $0.225B 0.00
Kamada (KMDA) Israel $0.221B 8.58
Cerecor (CERC) United States $0.220B 0.00
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Avid Bioservices (CDMO) United States $0.220B 0.00
ChromaDex (CDXC) United States $0.219B 0.00
Pfenex (PFNX) United States $0.219B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.214B 0.00
IDEAYA BIOSCI (IDYA) United States $0.213B 0.00
Enochian BioSciences (ENOB) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Cel-Sci (CVM) United States $0.206B 0.00
Enzo Biochem (ENZ) United States $0.204B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.202B 0.00
Affimed (AFMD) Germany $0.202B 0.00
Kala Pharmaceuticals (KALA) United States $0.190B 0.00
Mersana Therapeutics (MRSN) United States $0.187B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.183B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 10.41
Compugen (CGEN) Israel $0.178B 0.00
Solid Biosciences (SLDB) United States $0.177B 0.00
HOOKIPA PHARMA (HOOK) United States $0.177B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
CorMedix Inc (CRMD) United States $0.173B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
OvaScience (MLND) United States $0.170B 0.00
Dyadic (DYAI) United States $0.167B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.167B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
Liquidia Technologies (LQDA) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.159B 0.00
Anavex Life Sciences (AVXL) United States $0.158B 0.00
Intec Pharma (NTEC) Israel $0.158B 0.00
Kezar Life Sciences (KZR) United States $0.155B 0.00
APPLIED THERAPT (APLT) United States $0.154B 0.00
BioTime (BTX) United States $0.154B 10.30
Checkpoint Therapeutics (CKPT) United States $0.153B 0.00
Mustang Bio (MBIO) United States $0.152B 0.00
Aduro Biotech (ADRO) United States $0.151B 0.00
Menlo Therapeutics (MNLO) United States $0.151B 0.00
XOMA (XOMA) United States $0.149B 0.00
SESEN BIO, INC (SESN) United States $0.143B 0.00
TOCAGEN INC (TOCA) United States $0.138B 0.00
TREVI THERAPTCS (TRVI) United States $0.137B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
Verastem (VSTM) United States $0.129B 0.00
Eton Pharmaceuticals (ETON) United States $0.127B 0.00
Axovant Sciences (AXGT) United States $0.126B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.124B 0.00
VolitionRX (VNRX) Singapore $0.121B 0.00
Novavax (NVAX) United States $0.120B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Fortress Biotech (FBIO) United States $0.116B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Aptose Biosciences (APTO) Canada $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.106B 0.00
INmune Bio (INMB) United States $0.106B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.105B 0.00
Equillium (EQ) United States $0.104B 0.00
Arbutus Biopharma (ABUS) Canada $0.103B 0.00
NantKwest (NK) United States $0.103B 0.00
Trevena (TRVN) United States $0.103B 0.00
Aptinyx (APTX) United States $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.101B 0.00
Selecta Biosciences (SELB) United States $0.099B 0.00
Allena Pharmaceuticals (ALNA) United States $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.090B 0.00
InflaRx (IFRX) Germany $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.078B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.075B 0.00
Cohbar (CWBR) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.073B 0.00
Signal Genetics (MGEN) United States $0.073B 0.00
Applied Genetic Technologies (AGTC) United States $0.073B 39.90
VTv Therapeutics (VTVT) United States $0.072B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Cocrystal Pharma (COCP) United States $0.070B 73.33
Orgenesis (ORGS) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.066B 0.00
OVID THERAPEUTC (OVID) United States $0.065B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Alcobra (ARCT) United States $0.065B 0.00
Hoth Therapeutics (HOTH) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
VBI Vaccines (VBIV) United States $0.063B 0.00
ScPharmaceuticals (SCPH) United States $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Moleculin Biotech (MBRX) United States $0.052B 0.00
Ophthotech (ISEE) United States $0.052B 0.00
Zosano Pharma (ZSAN) United States $0.050B 0.00
Curis (CRIS) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.049B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Entera Bio (ENTX) Israel $0.043B 0.00
Cidara Therapeutics (CDTX) United States $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
VIVUS (VVUS) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
AZURRX BIOPHARM (AZRX) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.032B 0.00
Edge Therapeutics (PDSB) United States $0.032B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.031B 0.00
Aytu Bioscience (AYTU) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Bison Capital Acquisition (XYN) China $0.025B 0.00
Histogenics (HSGX) United States $0.023B 0.00
Oragenics (OGEN) United States $0.023B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
GTx (ONCT) United States $0.022B 0.00
Sophiris Bio (SPHS) United States $0.021B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
OncoSec Medical (ONCS) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.014B 0.00
Aileron Therapeutics (ALRN) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Motif Bio Plc (MTFB) United States $0.012B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
Therapix Biosciences (TRPX) Israel $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
IMMURON LTD (IMRN) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Neuralstem (CUR) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (ARMP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00